SEC Form 4 · accession 0001179110-15-001278
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John W Smither
Officer — Chief Financial Officer
Period of report
Jan 23, 2015
Accepted (ET)
Jan 27, 2015 · 5:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 20, 2014 | G | 16,200 | $0.00 | D | 6,216 | D | |
| Common StockF2 | Jan 7, 2015 | G | 6,216 | $0.00 | D | 0 | D | |
| Common StockF4 | Jan 23, 2015 | S | 2,000 | $35.47 | D | 20,416 | I | See Footnote |
| Common StockF4 | Jan 23, 2015 | S | 1,000 | $36.00 | D | 19,416 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were transferred to the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees on September 20, 2014.
- F2These shares were transfered to the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees on January 7, 2015.
- F3The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan which expires January 22, 2016.
- F4Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees.